Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is a rare genetic disorder characterised by numerous renal cysts, the progressive expansion of which can impact kidney function and lead eventually to renal failure. Tolvaptan is the only disease-modifying drug approved for the treatment of ADPKD,...

Full description

Saved in:
Bibliographic Details
Main Authors: Philip W. Brownjohn (Author), Azedine Zoufir (Author), Daniel J. O'Donovan (Author), Saatviga Sudhahar (Author), Alexander Syme (Author), Rosemary Huckvale (Author), John R. Porter (Author), Hester Bange (Author), Jane Brennan (Author), Neil T. Thompson (Author)
Format: Book
Published: Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available